Real-world performance of an AI system for diabetic retinopathy screening

Retinal Diseases

Impact of the era of diabetes onset in a national care system on the prevalence of retinopathy and microalbuminuria in people living with type 1 diabetes 15 years post-diagnosis: A cross-sectional, real-world observational study

Diabetes Obes Metab

Lavens A, De Block C, Oriot P, Philips JC, Vandenbroucke M, Crenier L, Nobels F, Mathieu C, Belgian Group of Experts IQED

doi: 10.1111/dom.70049

Retinal Diseases

Progression of diabetic retinopathy in a longitudinal real-world study of patients in primary care

BMC Ophthalmol

Lalwani G, Wykoff CC, Briggs J, Lin CY, Steffen V, Haskova Z

doi: 10.1186/s12886-025-04307-1

Retinal Diseases

Prospective validation of deep-learning algorithms for diabetic retinopathy screening: A systematic review and meta-analysis

Surv Ophthalmol

Wang TW, Luo WT, Tu YK, Chou YB, Wu YT

doi: 10.1016/j.survophthal.2025.11.012

Macular DiseasesRetinal Diseases

Port Delivery System With Ranibizumab vs Monitoring in Nonproliferative Diabetic Retinopathy Without Macular Edema: The Pavilion Randomized Clinical Trial

JAMA Ophthalmol

Pieramici DJ, Awh CC, Chang M, Emanuelli A, Holekamp NM, Hu AY, Suñer IJ, Wykoff CC, Brittain C, Howard D, Quezada-Ruiz C, Santhanakrishnan A, Latkany P

doi: 10.1001/jamaophthalmol.2025.0001

Macular Diseases

First-year real-world outcomes of faricimab in clinically significant diabetic macular oedema: a Swiss retina research network report

BMJ Open Ophthalmol

Saad A, Plasencia C, Garweg J, Pfister IB, Munk MR, Eandi CM, Zweifel SA, Grimaldi G, Bartolomeo N, Stillenmunkes R, Schild C, Cattaneo J, Gabathuler F, Menghini M, Ambersin A, Froehlich J, Artemiev D, Weinberger A, Mohamed H, Somfai GM, Hatz K

doi: 10.1136/bmjophth-2025-002467

Macular DiseasesRetinal Diseases

Visual outcomes and anatomical biomarkers of Faricimab for diabetic macular edema in the J-CREST real-world comparison of naïve and treated eyes

Sci Rep

Murao F, Yanai R, Kusuhara S, Abe Y, Shimura M, Ohara H, Terasaki H, Sugimoto M, Matsubara H, Hirano Y, Kinoshita T, Tsujinaka H, Seki K, Iwase T, Mitamura Y, J-CREST

doi: 10.1038/s41598-025-20300-6

Retinal Diseases

Rates, Risk Factors, and Progression of Diabetic Retinopathy in Children with Type 1 Diabetes: A 15-Year Retrospective Study from a Regional Center in New Zealand

Pediatr Diabetes

Winter T, Derraik JGB, Jefferies CA, Hofman PL, Shand JAD, Braatvedt GD, Misra SL

doi: 10.1155/2024/5893771

Glaucoma and Ocular Pressure

Risk of Dementia in Type 2 Diabetes Patients with Open-Angle Glaucoma: Insights from a Nationwide Real-World Cohort Study

Am J Ophthalmol

Zhou J, Lee DA, Talebi Y, Wu G, Wu H

doi: 10.1016/j.ajo.2026.02.003

Macular DiseasesRetinal Diseases

Impact of diabetes and diabetic retinopathy on neovascular exudative age-related macular degeneration

Acta Ophthalmol

Viggiano P, Santoro M, Boscia G, Porreca A, Borrelli E, Bacherini D, Lombardi L, Fumarola R, Grassi MO, Termite AC, Reibaldi M, Alessio G, Sadda S, Boscia F

doi: 10.1111/aos.17502

Related content

Impact of the era of diabetes onset in a national care system on the prevalence of retinopathy and microalbuminuria in people living with type 1 diabetes 15 years post-diagnosis: A cross-sectional, real-world observational study

Progression of diabetic retinopathy in a longitudinal real-world study of patients in primary care

Prospective validation of deep-learning algorithms for diabetic retinopathy screening: A systematic review and meta-analysis

Port Delivery System With Ranibizumab vs Monitoring in Nonproliferative Diabetic Retinopathy Without Macular Edema: The Pavilion Randomized Clinical Trial

First-year real-world outcomes of faricimab in clinically significant diabetic macular oedema: a Swiss retina research network report

Visual outcomes and anatomical biomarkers of Faricimab for diabetic macular edema in the J-CREST real-world comparison of naïve and treated eyes

Rates, Risk Factors, and Progression of Diabetic Retinopathy in Children with Type 1 Diabetes: A 15-Year Retrospective Study from a Regional Center in New Zealand

Risk of Dementia in Type 2 Diabetes Patients with Open-Angle Glaucoma: Insights from a Nationwide Real-World Cohort Study

Impact of diabetes and diabetic retinopathy on neovascular exudative age-related macular degeneration